Covered recipient · General Payments record
KEVIN XAVIER FARLEY
Allopathic & Osteopathic Physicians Orthopaedic Surgery
General Payments · PY2021–2024
$5,744.83
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,362.26 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Stryker Corporation | $658.32 | 7 |
| Zimmer Biomet Holdings, Inc. | $145.89 | 1 |
| Heron Therapeutics, Inc. | $121.35 | 1 |
| BIOCOMPOSITES INC | $110.88 | 1 |
| Amgen Inc. | $100.80 | 1 |
| Pinnacle, Inc | $99.99 | 2 |
| SI-BONE, INC. | $51.36 | 1 |
| Paragon 28, Inc. | $49.50 | 1 |
| ZIMVIE INC. | $24.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $100.80 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111572620 | CMS |
| BIOCOMPOSITES INC | $110.88 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146434274 | CMS |
| Heron Therapeutics, Inc. | $121.35 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147246068 | CMS |
| Paragon 28, Inc. | $49.50 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138433325 | CMS |
| Pinnacle, Inc | $31.82 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126998701 | CMS |
| Pinnacle, Inc | $68.17 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126998699 | CMS |
| SI-BONE, INC. | $51.36 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120057802 | CMS |
| Stryker Corporation | $7.69 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825727 | CMS |
| Stryker Corporation | $156.24 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825729 | CMS |
| Stryker Corporation | $22.73 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825731 | CMS |
| Stryker Corporation | $101.02 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825733 | CMS |
| Stryker Corporation | $67.35 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825735 | CMS |
| Stryker Corporation | $166.64 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825737 | CMS |
| Stryker Corporation | $136.65 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119825739 | CMS |
| Zimmer Biomet Holdings, Inc. | $145.89 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1155045259 | CMS |
| ZIMVIE INC. | $24.17 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142566563 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.